Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for chronic pelvic pain and sexual satisfaction in endometriosis
IRCT20091012002576N20Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in endometriosis, sponsored by Tehran University of Medical Sciences. Primary endpoints: Chronic pelvic pain intensity and Sexual satisfaction. Started Sep 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20091012002576N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N20.